Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections.

Bakowski MA, McNamara CW.

Trop Med Infect Dis. 2019 Jul 18;4(3). pii: E108. doi: 10.3390/tropicalmed4030108. Review.

2.

Discovery of Kirromycins with Anti- Wolbachia Activity from Streptomyces sp. CB00686.

Xu Z, Fang SM, Bakowski MA, Rateb ME, Yang D, Zhu X, Huang Y, Zhao LX, Jiang Y, Duan Y, Hull MV, McNamara CW, Shen B.

ACS Chem Biol. 2019 Jun 21;14(6):1174-1182. doi: 10.1021/acschembio.9b00086. Epub 2019 May 10.

PMID:
31074963
3.

Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.

Bakowski MA, Shiroodi RK, Liu R, Olejniczak J, Yang B, Gagaring K, Guo H, White PM, Chappell L, Debec A, Landmann F, Dubben B, Lenz F, Struever D, Ehrens A, Frohberger SJ, Sjoberg H, Pionnier N, Murphy E, Archer J, Steven A, Chunda VC, Fombad FF, Chounna PW, Njouendou AJ, Metuge HM, Ndzeshang BL, Gandjui NV, Akumtoh DN, Kwenti TDB, Woods AK, Joseph SB, Hull MV, Xiong W, Kuhen KL, Taylor MJ, Wanji S, Turner JD, Hübner MP, Hoerauf A, Chatterjee AK, Roland J, Tremblay MS, Schultz PG, Sullivan W, Chu XJ, Petrassi HM, McNamara CW.

Sci Transl Med. 2019 May 8;11(491). pii: eaav3523. doi: 10.1126/scitranslmed.aav3523.

PMID:
31068442
4.

Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.

Jacobs RT, Lunde CS, Freund YR, Hernandez V, Li X, Xia Y, Carter DS, Berry PW, Halladay J, Rock F, Stefanakis R, Easom E, Plattner JJ, Ford L, Johnston KL, Cook DAN, Clare R, Cassidy A, Myhill L, Tyrer H, Gamble J, Guimaraes AF, Steven A, Lenz F, Ehrens A, Frohberger SJ, Koschel M, Hoerauf A, Hübner MP, McNamara CW, Bakowski MA, Turner JD, Taylor MJ, Ward SA.

J Med Chem. 2019 Mar 14;62(5):2521-2540. doi: 10.1021/acs.jmedchem.8b01854. Epub 2019 Feb 26.

5.

Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Roth A, Maher SP, Conway AJ, Ubalee R, Chaumeau V, Andolina C, Kaba SA, Vantaux A, Bakowski MA, Thomson-Luque R, Adapa SR, Singh N, Barnes SJ, Cooper CA, Rouillier M, McNamara CW, Mikolajczak SA, Sather N, Witkowski B, Campo B, Kappe SHI, Lanar DE, Nosten F, Davidson S, Jiang RHY, Kyle DE, Adams JH.

Nat Commun. 2018 Jun 8;9(1):2317. doi: 10.1038/s41467-018-04817-1.

6.

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Roth A, Maher SP, Conway AJ, Ubalee R, Chaumeau V, Andolina C, Kaba SA, Vantaux A, Bakowski MA, Thomson-Luque R, Adapa SR, Singh N, Barnes SJ, Cooper CA, Rouillier M, McNamara CW, Mikolajczak SA, Sather N, Witkowski B, Campo B, Kappe SHI, Lanar DE, Nosten F, Davidson S, Jiang RHY, Kyle DE, Adams JH.

Nat Commun. 2018 May 9;9(1):1837. doi: 10.1038/s41467-018-04221-9. Erratum in: Nat Commun. 2018 Jun 8;9(1):2317.

7.

Cell-to-cell spread of microsporidia causes Caenorhabditis elegans organs to form syncytia.

Balla KM, Luallen RJ, Bakowski MA, Troemel ER.

Nat Microbiol. 2016 Aug 22;1(11):16144. doi: 10.1038/nmicrobiol.2016.144.

8.

Three-dimensional fluorescent microscopy via simultaneous illumination and detection at multiple planes.

Ma Q, Khademhosseinieh B, Huang E, Qian H, Bakowski MA, Troemel ER, Liu Z.

Sci Rep. 2016 Aug 16;6:31445. doi: 10.1038/srep31445.

9.

Characterization of microsporidia-induced developmental arrest and a transmembrane leucine-rich repeat protein in Caenorhabditis elegans.

Luallen RJ, Bakowski MA, Troemel ER.

PLoS One. 2015 Apr 13;10(4):e0124065. doi: 10.1371/journal.pone.0124065. eCollection 2015.

10.

Genome Sequence of the Microsporidian Species Nematocida sp1 Strain ERTm6 (ATCC PRA-372).

Bakowski MA, Priest M, Young S, Cuomo CA, Troemel ER.

Genome Announc. 2014 Sep 18;2(5). pii: e00905-14. doi: 10.1128/genomeA.00905-14.

11.

Ubiquitin-mediated response to microsporidia and virus infection in C. elegans.

Bakowski MA, Desjardins CA, Smelkinson MG, Dunbar TL, Lopez-Moyado IF, Rifkin SA, Cuomo CA, Troemel ER.

PLoS Pathog. 2014 Jun 19;10(6):e1004200. doi: 10.1371/journal.ppat.1004200. eCollection 2014 Jun. Erratum in: PLoS Pathog. 2014 Aug;10(8):e1004371. Dunbar, Tiffany A [corrected to Dunbar, Tiffany L].

12.

Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth.

Cuomo CA, Desjardins CA, Bakowski MA, Goldberg J, Ma AT, Becnel JJ, Didier ES, Fan L, Heiman DI, Levin JZ, Young S, Zeng Q, Troemel ER.

Genome Res. 2012 Dec;22(12):2478-88. doi: 10.1101/gr.142802.112. Epub 2012 Jul 18.

13.

The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole.

Bakowski MA, Braun V, Lam GY, Yeung T, Heo WD, Meyer T, Finlay BB, Grinstein S, Brumell JH.

Cell Host Microbe. 2010 Jun 25;7(6):453-62. doi: 10.1016/j.chom.2010.05.011.

14.

Salmonella-containing vacuoles: directing traffic and nesting to grow.

Bakowski MA, Braun V, Brumell JH.

Traffic. 2008 Dec;9(12):2022-31. doi: 10.1111/j.1600-0854.2008.00827.x. Epub 2008 Oct 8. Review.

15.

Role for myosin II in regulating positioning of Salmonella-containing vacuoles and intracellular replication.

Wasylnka JA, Bakowski MA, Szeto J, Ohlson MB, Trimble WS, Miller SI, Brumell JH.

Infect Immun. 2008 Jun;76(6):2722-35. doi: 10.1128/IAI.00152-08. Epub 2008 Apr 14.

16.

SopD acts cooperatively with SopB during Salmonella enterica serovar Typhimurium invasion.

Bakowski MA, Cirulis JT, Brown NF, Finlay BB, Brumell JH.

Cell Microbiol. 2007 Dec;9(12):2839-55. Epub 2007 Aug 13.

PMID:
17696999
17.

Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole.

Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH.

J Biol Chem. 2006 Apr 21;281(16):11374-83. Epub 2006 Feb 22.

18.

Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo.

Rosonina E, Ip JY, Calarco JA, Bakowski MA, Emili A, McCracken S, Tucker P, Ingles CJ, Blencowe BJ.

Mol Cell Biol. 2005 Aug;25(15):6734-46.

19.

Alternative splicing of conserved exons is frequently species-specific in human and mouse.

Pan Q, Bakowski MA, Morris Q, Zhang W, Frey BJ, Hughes TR, Blencowe BJ.

Trends Genet. 2005 Feb;21(2):73-7.

PMID:
15661351
20.

The functional landscape of mouse gene expression.

Zhang W, Morris QD, Chang R, Shai O, Bakowski MA, Mitsakakis N, Mohammad N, Robinson MD, Zirngibl R, Somogyi E, Laurin N, Eftekharpour E, Sat E, Grigull J, Pan Q, Peng WT, Krogan N, Greenblatt J, Fehlings M, van der Kooy D, Aubin J, Bruneau BG, Rossant J, Blencowe BJ, Frey BJ, Hughes TR.

J Biol. 2004;3(5):21. doi: 10.1186/jbiol16. Epub 2004 Dec 6.

21.

Transcriptional activators control splicing and 3'-end cleavage levels.

Rosonina E, Bakowski MA, McCracken S, Blencowe BJ.

J Biol Chem. 2003 Oct 31;278(44):43034-40. Epub 2003 Aug 25.

Supplemental Content

Loading ...
Support Center